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Objective: The aim of this study was to explore mental health care utilization patterns in 
primary and specialized mental health care of people with unexplained or explained physical 
symptoms.
Methods: Data were derived from the first wave of the Netherlands Mental Health Survey 
and Incidence Study-2, a nationally representative face-to-face cohort study among the general 
population aged 18–64 years. We selected subjects with medically unexplained symptoms (MUS) 
only (MUSonly; n=177), explained physical symptoms only (PHYonly, n=1,952), combined 
MUS and explained physical symptoms (MUS + PHY, n=209), and controls without physical 
symptoms (NONE, n=4,168). We studied entry into mental health care and the number of treat-
ment contacts for mental problems, in both primary care and specialized mental health care. 
Analyses were adjusted for sociodemographic characteristics and presence of any 12-month 
mental disorder assessed with the Composite International Diagnostic Interview 3.0.
Results: At the primary care level, all three groups of subjects with physical symptoms showed 
entry into care for mental health problems significantly more often than controls. The adjusted 
odds ratios were 2.29 (1.33, 3.95) for MUSonly, 1.55 (1.13, 2.12) for PHYonly, and 2.25 
(1.41, 3.57) for MUS + PHY. At the specialized mental health care level, this was the case only 
for MUSonly subjects (adjusted odds ratio 1.65 [1.04, 2.61]). In both the primary and special-
ized mental health care, there were no significant differences between the four groups in the 
number of treatment contacts once they entered into treatment.
Conclusion: All sorts of physical symptoms, unexplained as well as explained, were associated 
with significant higher entry into primary care for mental problems. In specialized mental health 
care, this was true only for MUSonly. No differences were found in the number of treatment 
contacts. This warrants further research aimed at the content of the treatment contacts.
Keywords: medically unexplained symptoms, explained physical symptoms, mental health 
care use, general population
Introduction
Background and rationale
Little is known about how physical symptoms impact mental health care use. Physical 
symptoms can either be explained, in the context of a somatic illness, or lack such an 
explanation. Medically unexplained symptoms (MUS) are defined as physical symp-
toms where a physician cannot find a specific cause.1 People with MUS are known to 
have comorbid mental disorders, such as mood and anxiety disorders, more often in 
comparison to healthy controls in the general population2 in primary and specialized 
care3 and in tertiary care.4 This raises questions about the influence of MUS on mental 
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health care use. Individuals with three or more concomitant 
physical symptoms, whether medically unexplained or not, 
have greater odds of having used mental health care services 
in the past year.5 However, it is not known whether this 
would be the same after adjustment for mental disorders 
and whether it has an impact on the number of treatment 
contacts. Entry into mental health care and the number of 
treatment contacts might be influenced by unsuccessful 
referrals in which patients who need referral do not reach 
mental health care.6
Opinions differ regarding the relative mental health 
care utilization pattern of people with MUS versus people 
with explained physical symptoms. Evidence suggests that 
the existence of comorbid somatic conditions increases the 
mental health care utilization in people with a common 
mental disorder;7 however, whether the existence of MUS 
also increases entry into mental health care is unknown. 
On the one hand, it may be assumed that people with MUS 
would seek treatment in specialized mental health care 
for their problems associated with MUS, because general 
practitioners (GPs) find it difficult to treat these problems.6 
In that case, the complexity of the problems might lead to 
more treatment contacts. On the other hand, it has also been 
suggested that people with MUS attend somatic health care 
services frequently8 but would resist mental health care 
referral,9,10 as they would prefer to seek a somatic explana-
tion for their physical symptoms, instead of getting mental 
health treatment.10 In addition, if in such a case a GP would 
succeed in referring the person to specialized mental health 
care; the offered treatment might not fit with the request of 
the patient, which might lead to an early ending of the therapy 
and consequently a low number of treatment appointments. 
Finally, the number of treatment contacts might be influ-
enced both negatively and positively or even might show no 
overall differences in the number of treatment contacts due 
to conflicting influences.
It is not known whether the group of people with MUS 
in the general population is comparable to the “selected” 
groups of patients whose mental health care use patterns 
have been investigated.5–8,10,11 More insight into the mental 
health care use patterns of people with either MUS, explained 
physical symptoms, or both can give us clues about what is 
needed to optimize mental health care for these groups. The 
outcomes of this study inform us whether the focus of future 
research should be how to optimize entry into care or gaining 
more insight into the content and effects of delivered mental 
health care to people with concomitant physical symptoms. 
This warrants the current investigation in a psychiatric study 
with a large representative sample from the Dutch general 
population that has not been selected based on health care 
use, involving subjects with both unexplained and explained 
physical symptoms.
Objective
The objective was to explore how physical symptoms are 
associated with mental health care use in both primary 
and specialized mental health care. We therefore com-
pare service use patterns for subjects with MUS only 
(MUSonly), with explained physical symptoms only 
(PHYonly), with both MUS and explained physical symp-
toms and for controls without symptoms, with respect to 
entry into mental health care and the number of treatment 
contacts once one has entered care. Based on the literature 
mentioned earlier, we hypothesize that subjects with both 
MUS and explained physical symptoms more often enter 
mental health care.
Methods
Study design
In this general population study, we examine mental health 
care use in terms of entry into primary and specialized 
mental health care, which is defined as at least one treatment 
contact. Furthermore, we examine the number of visits to 
mental health care. Subjects were divided into primary care 
only for mental problems and specialized mental health care 
(regardless of whether they also used primary care, compa-
rable to earlier research).12 We report our findings according 
to the STrengthening the Reporting of OBservational studies 
in Epidemiology (STROBE) statement.13
Setting and participants
Data were derived from the first wave (2007–2009) of the 
Netherlands Mental Health Survey and Incidence Study-2 
(NEMESIS-2).14,15 Methods of NEMESIS-2 are described 
elsewhere.14 Briefly, NEMESIS-2 is a nationally represen-
tative face-to-face population study including subjects aged 
18–64 years at baseline. NEMESIS-2 was approved by the 
Medical Ethics Review Committee for Institutions on Mental 
Health Care (METIGG). After being informed about the 
study, subjects provided written informed consent.
NEMESIS-2 is based on a multistage, stratified 
random sampling of households, with one respondent aged 
18–64 years randomly selected in each household for a 
face-to-face interview. The interviews were conducted by 
professional, experienced interviewers. The response rate 
was 65.1%. The sample was nationally representative, 
although younger subjects were somewhat underrepresented. 
Of the total group of 6,646 baseline subjects, 140 subjects 
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received a shortened version of the questionnaire, and as a 
consequence they did not receive questions about somatic 
disorders. Therefore, the number of subjects in the current 
analyses was 6,506.
Variables
service use
We examined 12-month mental health care use separately for 
two health care sectors: primary care and specialized mental 
health care. Within these sectors, we examined two stages 
of the care process: entry into mental health care (defined as 
the presence of any mental health contact) and, after entry 
into care, the number of mental health care visits. This is 
comparable to earlier research designs.12
The primary care sector included GPs, company doctors, 
social workers, home care or district nurses, physiotherapists 
or haptonomists, medical specialists, and other professionals 
working within the general medical care sector. As described 
in an earlier article,7 the primary care setting is the original 
point of service entry in the Netherlands. Patients need refer-
ral of their GP before they can go to a mental health prac-
titioner. Common mental health disorders can be treated in 
the primary care setting by the abovementioned primary care 
practitioners. When a mental disorder is chronic, more severe, 
or complex, patients can be referred by the GP to a specialist 
mental health treatment setting. The specialized mental health 
care sector included psychiatrists, psychologists, psycho-
therapists, and part-time or full-time psychiatric treatment.
Definition of MUS
For this study, we use the following definition of MUS: 
presence of one or more physical symptom(s) in the past 
12 months for which no adequate organ pathology or 
pathophysiological basis was found, and for which, according 
to the subject, a physician was consulted and/or medication 
was received, and which caused discomfort and functional 
impairment in the past 4 weeks as measured by the physical 
health subscales of the Short Form 36.1,16–18 We included 
the presence of discomfort and functional impairment in 
the definition, to stay in line with the Somatoform disorders 
in Diagnostic and Statistical Manual of Mental Disorders, 
fourth edition, text revision (DSM-IV-TR)19 and the DSM-V 
somatic symptom disorder (SSD),20 in which both require 
discomfort and functional impairment.
Data sources and measurement
For MUS, explained physical symptoms, and mental disor-
ders, measures were used as described in Table 1 (which was 
also published in our previous study).2
Bias
We made the following efforts to address potential sources 
of bias. As we expect the presence of a mental disorder to 
influence service use, analyses were adjusted for the presence 
of any 12-month mental disorder. These mental disorders 
were assessed with the Composite International Diagnostic 
Interview (CIDI) 3.0 and are described in Table 1 (mood, 
anxiety, and substance use disorders). We also adjusted the 
analyses for sociodemographics. Furthermore, a strict defi-
nition for the self-report of physical symptoms was used: 
subjects had to have visited or be treated by a physician or use 
prescribed medication, for the particular physical symptom 
to be seen as present.
Quantitative variables and study size
Operationalization of four groups
The following groups were distinguished: first, those who 
had MUS, but no physical symptoms that could be explained 
by physical disorders, were grouped as “MUSonly” (n=177). 
Second, subjects with explained PHYonly, which were the 
physical symptoms in the checklist minus those symptoms 
that were considered to be MUS, were grouped as “PHYonly” 
(n=1,952). Third, those who had both MUS and explained 
physical symptoms were grouped as “MUS + PHY” (n=209). 
The control group included subjects with no MUS and no 
explained physical symptoms (“NONE”, n=4,168).
statistical methods
All analyses were performed with STATA Version 12.1, 
using weighted data to correct for differences in the response 
rates of several sociodemographic groups, and differences 
in the probability of the selection of subjects within house-
holds. In our analyses, we defined the complex sampling 
and recruitment procedure of the study in order to correct 
for possible clustering in the data resulting in robust standard 
errors (SEs).35
Summary statistics (ie, tables of frequencies) were used to 
describe the sociodemographic characteristics of the above-
mentioned four groups of subjects, MUSonly, PHYonly, 
MUS + PHY, and NONE (Table 2).
In Table 3, entry into care for mental health problems 
among the four groups is described in percentages and 
odds ratios (ORs). To investigate whether group member-
ship played an independent role in explaining service use, 
logistic regression analyses were performed, controlling for 
sociodemographic characteristics (sex, age, living situation, 
education, and employment situation; model 1) and also for 
any 12-month mental disorder (model 2). In these analyses, 
the group NONE was used as the reference group. In Table 4, 
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Table 1 Measures
Measurement Measuring instrument
Medically unexplained physical symptoms
Subjects were considered to have MUS if their condition applied to 
both criteria mentioned below
Interview based on questionnaire of physical symptoms
1. Presence of one of the following physical symptoms, experienced 
in the past 12 months, for which the subjects indicated that they 
visited a physician or received medication:
a) Disturbing intestinal symptoms, existing longer than 3 months, for 
which no indication of an explanation existed21–23
b) Back problems existing longer than 3 months, for which no 
indication of an explanation existed22,24
c) Other illness or physical symptoms that are long lasting (open 
question) and unexplained
All physical symptoms mentioned here (verbatim responses) were 
checked independently by two physicians (Jonna van Eck van der Sluijs 
and christina van der Feltz-cornelis) to indicate whether or not 
they could be considered medically unexplained physical symptoms in 
general. If their judgments were not the same, they deliberated until 
consensus was achieved
We checked the answers on the open questions to see if an 
explanation was given about the intestinal symptoms, such as 
pancreatitis or hernia abdominalis, or the back problem, such as neck 
hernia or paraplegia
If this was the case, we did not include the subject in the unexplained 
group, but in the explained group
Examples of general symptoms that we considered to be medically 
unexplained physical symptoms are fibromyalgia, fatigue (such as 
chronic fatigue syndrome), pain without medical explanation (such as 
stress-related pain in muscles), and physical symptoms accompanied 
with phrases such as “they cannot find anything” or “if only I knew”
2. Presence of limited functioning reported in the past 4 weeks, 
as indicated by two or more of the physical health subscales  
of the SF-3617,18
Interview based on SF-36 physical health subscales:
a) Physical functioning: some or severe limitations in at least one of the 
ten items in this category
b) Physical role functioning: any limitation reported in at least one of 
the four items in this category
c) Bodily pain: pain leading to any limitation in normal work activities
d) General health: describes mental or physical health as poor, and/or 
negative expectations about one’s health
Explained physical symptoms
Respiratory disorders (asthma, chronic obstructive pulmonary disease, 
chronic bronchitis, emphysema), cardiovascular disorders (severe 
heart disease, heart attack, hypertension, stroke), stomach or intestinal 
ulcers, severe intestinal symptoms (only if an explanation about the 
cause was given such as pancreatitis, hernia abdominalis), diabetes, 
thyroid disorder, chronic back pain (only if an explanation about the 
cause was given such as neck hernia, paraplegia, caused by accident), 
arthritis, migraine, cancer, impaired vision, or hearing
Interview based on questionnaire of physical symptoms, in which the 
main physical symptoms of the CBS (Netherlands Central Bureau of 
Statistics) questionnaire can be found.25 These physical symptoms were 
based on self-report by the subjects during the interview, and not 
by medical records.26 Comparisons between self-reports of chronic 
physical disorders and medical records show moderate-to-good 
concordance.27–29 Subjects were considered to have physical symptoms 
if they reported to have been treated or monitored by a physician 
in the prior 12 months for one or more of the disorders, and after 
confirmation by two physicians, in duplicate, that symptoms were 
considered to be medically explained
covariate: DSM-IV mental disorders ciDi 3.026,30,31
DSM-IV mood disorder (major depression, dysthymia, bipolar disorder), 
anxiety disorder (panic disorder, agoraphobia [without panic disorder], 
social phobia, specific phobia, generalized anxiety disorder) and 
substance use disorder (alcohol/drug abuse and dependence). In this 
article, we combined the 12-month mood, anxiety, and substance use 
disorders, to form the group “any 12-month mental disorder”
Interviews were conducted by professional, experienced interviewers. 
Clinical calibration studies conducted in various countries have found 
that ciDi 3.032 and earlier versions33,34 assess anxiety and mood and 
substance use disorders with generally good validity compared to 
blinded clinical reappraisal interviews
Abbreviations: CIDI, Composite International Diagnostic Interview Version 3.0; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, fourth edition; MUS, medically 
unexplained symptoms; sF-36, short Form 36.
the number of treatment contacts after entry into care among 
the four groups is described in means and incidence rate 
ratios. To investigate whether group membership played 
an independent role in explaining the number of mental 
health visits made after entry into care, multiple negative 
binomial regression analyses were performed,12 controlling 
for confounders variables (for sociodemographic character-
istics in model 1 and also for any 12-month mental disorder 
in model 2). Again, in these analyses, the group NONE 
was used as reference group. All analyses were performed 
with complete data of the 6,506 subjects, so there were no 
missing data.
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Table 2 Sociodemographic characteristics and mental health status of subjects with and without MUS and explained physical symptoms 
(N=6,506), in unweighted numbers and weighted column percentages
n MUSonly  
(n=177) (%)
PHYonly  
(n=1,952) (%)
MUS + PHY  
(n=209) (%)
NONE  
(n=4,168) (%)
P-value
sex
Female 3,589 60.4 55.9 67.2 45.4 ,0.0001
Partner status
With partner 4,419 65.5 71.6 73.9 65.3 0.0003
Age (years)
18–24 477 7.3 8.2 1.4 15.3
25–34 1,100 18.3 11.8 7.8 23.6
35–44 1,659 28.7 20.2 19.4 26.5
45–54 1,559 28.1 27.6 33.1 20.4
55–64 1,711 17.7 32.2 38.4 14.1 ,0.0001
employment situation
With paid job 4,858 65.0 71.3 50.3 80.3 ,0.0001
education
Primary, basic vocational 312 6.0 10.1 13.3 5.5
lower secondary 1,782 22.5 22.8 27.4 22.3
Higher secondary 2,095 46.4 42.4 41.2 41.2
Higher professional, university 2,317 25.2 24.7 18.1 31.0 ,0.0001
any 12-month mental disorder 1,090 30.5 20.0 28.8 15.4 ,0.0001
Abbreviations: MUS, medically unexplained symptoms; MUSonly, MUS, no explained physical symptoms; PHYonly, explained physical symptoms, no MUS; MUS + PHY, 
both MUS and explained physical symptoms; NONE, no explained physical symptoms, no MUS; P, P-values are related to the differences in sociodemographics between the 
four groups, not on a specific comparison.
Table 3 Entry into care for mental health problems among subjects with and without MUS and explained physical symptoms (N=6,506), 
in unweighted numbers, weighted column percentages, and weighted adjusted ORs with 95% CI
Type of physical 
symptoms
Primary care only Specialized mental health care
n % Model 1 Model 2 n % Model 1 Model 2
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
MUSonly (n=177) 16 10.5 2.89 (1.71, 4.90) 2.29 (1.33, 3.95) 29 14.4 2.40 (1.47, 3.92) 1.65 (1.04, 2.61)
PHYonly (n=1,952) 117 5.9 1.74 (1.26, 2.43) 1.55 (1.13, 2.12) 136 6.6 1.22 (0.93, 1.61) 1.00 (0.75, 1.33)
MUS + PHY (n=209) 21 9.8 2.89 (1.82, 4.60) 2.25 (1.41, 3.57) 26 10.4 1.58 (0.90, 2.77) 1.07 (0.62, 1.83)
NONE (n=4,168) 163 3.5 Ref Ref 240 5.5 Ref Ref
Notes: Bold values represent significant OR at the 0.05 level, two-sided test. Model 1: adjusted for sociodemographic characteristics (sex, age, living situation, employment 
situation, and education). Model 2: adjusted for sociodemographic characteristics (sex, age, living situation, employment situation, and education) and any 12-month mental 
disorder.
Abbreviations: CI, confidence interval; MUS, medically unexplained symptoms; OR, odds ratio; MUSonly, MUS, no explained physical symptoms; PHYonly, explained 
physical symptoms, no MUS; MUS + PHY, both MUS and explained physical symptoms; NONE, no explained physical symptoms, no MUS; Ref, reference category.
Table 4 Number of treatment contacts for mental health problems among those using primary care only for mental health problems 
(n=317) and among those using specialized mental health care (n=431), in unweighted numbers, mean, and weighted adjusted IRR with 
95% CI
Type of 
physical 
symptoms
Number of treatment contacts for mental health care 
(in primary care)
Number of treatment contacts (in specialized mental 
health care)
n Mean 
(SE)
Model 1 Model 2 n Mean 
(SE)
Model 1 Model 2
IRR (95% CI) IRR (95% CI) IRR (95% CI) IRR (95% CI)
MUSonly 16 4.7 (2.0) 0.76 (0.38, 1.51) 0.79 (0.41, 1.52) 29 19.4 (4.3) 1.04 (0.67, 1.63) 0.84 (0.51, 1.38)
PHYonly 117 5.8 (1.1) 1.24 (0.82, 1.86) 1.34 (0.89, 2.00) 136 13.0 (1.8) 0.73 (0.50, 1.07) 0.69 (0.46, 1.03)
MUS + PHY 21 5.7 (1.4) 1.29 (0.61, 2.71) 1.38 (0.68, 2.80) 26 19.7 (9.9) 1.24 (0.41, 3.77) 1.31 (0.39, 4.43)
NONe 163 5.1 (1.0) Ref Ref 240 19.2 (3.1) Ref Ref
Notes: Model 1: adjusted for sociodemographic characteristics (sex, age, living situation, employment situation, and education). Model 2: adjusted for sociodemographic 
characteristics (sex, age, living situation, employment situation, and education) and any 12-month mental disorder.
Abbreviations: CI, confidence interval; IRR, incidence rate ratio; MUS, medically unexplained symptoms; SE, standard error; MUSonly, MUS, no explained physical 
symptoms; PHYonly, explained physical symptoms, no MUS; MUS + PHY, both MUS and explained physical symptoms; NONE, no explained physical symptoms, no MUS; 
Ref, reference category.
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Results
Participants
Table 2 describes the sociodemographic characteristics of the 
four groups: MUSonly, explained PHYonly, both MUS and 
explained physical symptoms (MUS + PHY), and healthy 
controls (NONE). The sociodemographic characteristics 
of our sample, with the exception of the presence of any 
12-month mental disorder, were also described in our earlier 
article.2
Descriptive data
There were significant differences between the groups 
regarding the following sociodemographic variables: women 
more often had physical symptoms than men, irrespective of 
whether the symptoms were explained, unexplained or both. 
Although the majority had a partner, subjects in the MUS 
only group and in the NONE group more often were single 
than subjects in the PHYonly group and in the MUS + PHY 
group. Both groups with explained symptoms had signifi-
cantly more subjects in the higher age groups (55–64 years) 
than MUSonly and NONE. The employment rate in the 
MUS + PHY group was only 50.3%, while 80.3% of people in 
the control group had a paid job. Approximately 25% in both 
the MUSonly and PHYonly groups had a higher professional/
university education versus 18.1% in the MUS + PHY group 
and 31.0% of the NONE group. Any 12-month mental dis-
order was most prevalent in the MUSonly group.
Outcome data and main results
Mental health care use
The findings regarding entry into care are shown in Table 3. 
In the past 12 months, for mental health problems, 4.5% of 
the overall sample of 6,506 people used primary care only 
and 6.2% of the overall sample used specialized mental health 
care (not presented in Table 3). For mental health problems, 
MUSonly, PHYonly, and MUS + PHY groups used primary 
care more often compared to the control group. The adjusted 
ORs for MUSonly and MUS + PHY were the highest and 
almost equal; the OR for PHYonly was lower. After adjust-
ment for sociodemographic characteristics and the presence 
of any 12-month mental disorder, the ORs for MUSonly and 
MUS + PHY were ∼2.3 and for PHYonly 1.55.
The MUSonly group used specialized mental health 
care significantly more often compared to NONE. The OR 
adjusted for sociodemographic characteristics and the pres-
ence of any 12-month mental disorder was 1.65. For the 
PHYonly and MUS + PHY groups, no significant differences 
were found, when compared to NONE.
Number of treatment contacts
Table 4 shows the number of treatment contacts among those 
using health care for mental problems. Overall, the mean 
number of contacts in the past 12 months among those using 
primary mental health care only and specialized mental health 
care is 5.4 (SE =0.6) and 17.4 (SE =2.0), respectively. In both 
primary care and specialized mental health care, there were 
no significant differences in the number of treatment contacts 
between the MUSonly, PHYonly, and MUS + PHY groups 
compared to the NONE group.
Discussion
Key results
A higher chance of entry into primary care for mental health 
problems was seen in people with physical symptoms – 
irrespective of whether the symptoms were unexplained 
such as in MUS, explained by a chronic somatic condition, 
or a combination of the two – and also after adjustment for 
the presence of any mental disorder. All three categories of 
physical symptoms had a higher chance of entry into mental 
health care in the primary care setting. It is noteworthy that 
the category with the highest chance of entry into mental 
health care is the combined MUS + PHY category. It might 
well be the case that such a miscellaneous set of physical 
symptoms provides the subject with the highest need for 
mental health care. This is in line with previous findings that 
not only MUS but also explained physical symptoms are 
associated with mental disorder, and the higher the symptom 
count, the higher this association. Kroenke36 states that a 
higher somatic symptom count is a predictor of coexisting 
depressive or anxiety disorder. Recent stress, low self-
rated health, high severity of the somatic symptom, and the 
clinician’s perception that the patient encounter is difficult 
are other predictors of depression and anxiety.36 Escobar 
et al5 confirm that the number (three or more) of physical 
symptoms is more important than whether the symptoms are 
medically explained or not.
For subjects with MUS, entry into mental health care 
might be explained by their frequent dysfunctional cognitions 
(such as catastrophic thoughts) and feelings and behaviors 
regarding their physical symptoms (ie, fear of a serious 
physical disorder such as a heart attack leading to avoidance 
of exercise), which are reasons for consulting a physician 
for reassurance or treatment. These possible explanations 
could be explored in future research, for example, using the 
SSD-B Criteria Scale (SSD-12), a validated questionnaire 
assessing the aspects that are now used in the DSM-V as 
criterion B.37
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It should be noted that the label MUS covers a wide 
spectrum of conditions, and thus one could question whether 
the presence of MUS is the only reason for higher psychi-
atric morbidity, and thus need for mental health care, than 
healthy individuals. Nimnuan et al38 found that psychiatric 
morbidity per se was not associated with the presence of 
MUS in a hospital setting, but it was more likely in those 
with multiple symptoms. Another explanation may be that 
physical symptoms are misinterpreted symptoms of already 
existing mental disorders, ie, pain or weight loss in depres-
sion, muscle pain and fatigue in generalized anxiety disorder, 
and palpitations in panic disorder.20
In specialized mental health care, only subjects with MUS 
had an increased chance of at least one treatment contact 
after adjustment for the presence of any mental disorder. 
The availability of cognitive behavior treatment (CBT) for 
somatoform disorder might be of influence on this, given 
that it is a well-known treatment option.39–41 CBT is recom-
mended in the Dutch multidisciplinary guideline for MUS 
and somatoform disorders and can be offered by the GP or 
in the specialized mental health care, if the GP considers 
the patient to be too complex or when the patient–doctor 
relationship is perturbed.40 In addition to the CBT for MUS 
and somatoform disorder, specialist psychiatric attention may 
be required for other mental health problems associated with 
physical symptoms (unexplained or explained).2,42 Given 
that all people with physical symptoms (explained or unex-
plained) show more entry into primary care, but only people 
with MUS show more entry into specialized mental health 
care, MUS is apparently of higher influence than explained 
physical symptoms on the decision of the GP whether or not 
to refer to specialized mental health care.
In model 2, entry into care and the number of treatment 
contacts were adjusted for the presence of any 12-month 
mental disorder, because that will be the main reason for ask-
ing and receiving mental health care. This article gives insight 
into the influence of the presence of physical symptoms 
(unexplained or explained) on the received mental health 
care. The difficulty is how we should view those physical 
symptoms: are they a parameter of the mental disorder or 
does the mental disorder influence the perceived severity of 
the physical disorders, or both? Winkler et al43 showed that 
in primary health care odds of having pain, hypertension, 
or diabetes mellitus are particularly elevated in people with 
co-occurring depressive and anxiety disorder. Especially for 
pain, it has been questioned whether there is a causal rela-
tionship with mental disorders, given the strong association 
between the two.44,45 In some individuals, the mental disorder 
may in fact be the primary and more serious condition; in 
others this may be the physical disorder. After entry into 
care, there were no significant differences in the number of 
treatment contacts between groups for both settings. After 
entry into primary mental health care, the mean number of 
treatment contacts is ∼5 in all groups, which is the number 
of treatment sessions generally allotted to the general care 
psychologist. In specialized mental health care, the mean 
number of treatment contacts is between 13 and 20. This 
number of treatment contacts suggests that patients are not 
referred to specialized mental health care just to check if a 
mental disorder is present, but that they also receive treat-
ment. It also suggests that people with MUS in the general 
population are not equal to selected patient groups with MUS. 
In those selected groups, GPs have difficulties treating the 
MUS-related problems6 and patients resist referral to special-
ized mental health care.9,10 In this general population study, 
people with MUS were referred more often to specialized 
mental health care and the number of treatment contacts 
did not differ when compared to people without physical 
symptoms, meaning we did not find indications for difficul-
ties with referral or treatment. The exact content and results 
of this treatment are not known, however. Given the fact 
that depression as a risk factor for mortality is comparable 
to smoking,46 further research on the content and results of 
depression treatment is warranted: are the currently used 
treatments sufficient, or do people with combined physical 
and psychiatric complaints leave treatment insufficiently 
treated? Fear of stigmatization can also play a role in this by 
negatively influencing entry into care as well as the number 
of treatment contacts.47
Our first hypothesis is partly confirmed. We expected 
entry into care for mental health problems more often among 
subjects with MUS and/or explained physical symptoms. 
This was confirmed for primary care, but in specialized 
mental health care just for subjects with MUSonly. We did 
not have a specific expectation about the number of treatment 
contacts, because both an increase and a decrease could be 
hypothesized. This study showed that the number of treat-
ment contacts did not differ between the four groups. Appar-
ently, once an individual with physical symptoms has entered 
mental health care, his/her needs concerning the number of 
treatment contacts are the same if the physical symptoms are 
medically explained or unexplained symptoms.
Strengths and limitations
Important strengths of NEMESIS-2 are the large representa-
tive study sample of the adult general population, and the 
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use of a valid and reliable diagnostic instrument for mental 
disorders (CIDI 3.0). We combined the presence of one or 
more MUS with the presence of limited functioning, and 
thereby we approached the SSD as described in the DSM-V.20 
As we used an existing database, we divided the sample into 
four groups based on predefined clinical criteria without 
being able to view medical records. Although we had this 
limitation, we believe that our methods of operationaliza-
tion and classification are reasonable for MUS. Given that 
by definition the subjects in the MUS + PHY group had at 
least two physicals symptoms (one MUS and one PHY), 
the subjects in the MUSonly and in the PHYonly group 
at least one, and the subjects in NONE group no physical 
symptoms, we did not adjust our data for the number of 
physical symptoms.
Another limitation was that numbers became small in 
the various groups, but despite this we found significant 
differences for entry into care between the groups. Finally, 
for service use, and especially for the number of treatment 
contacts, recall problems might impact the respondents’ 
estimations, but it is difficult to gauge the influence of this 
bias on the results of our study. Yet, it does appear unlikely 
that people with MUS or explained physical symptoms would 
systematically over- or underestimate their visits to mental 
health care services.
Conclusion
This is the first study exploring mental health care utilization 
patterns in subjects with MUS or explained physical symp-
toms at population level. The overall mental health care use 
was in line with what we expected: for mental problems, entry 
into primary care as well as into specialized health care use 
was seen more often in subjects with MUSonly compared 
to healthy controls. The same is true for entry into primary 
care for the combination of MUS and explained physical 
symptoms, and for explained PHYonly; for these groups 
entry into specialized mental health care did not differ sig-
nificantly compared to people without physical symptoms. 
We learn from this that, despite the complexity and possibly 
strained patient–doctor relationships related to MUS,48 GPs 
do succeed in referring people with MUS to specialized 
mental health care. In both primary care and specialized 
mental health care, there were no significant differences in the 
number of treatment contacts between the groups. Based on 
this, we may conclude that in the general population, people 
with MUS are not as complex as selected groups of people 
with MUS. For health service planning, this means that 
similar services should be provided for people with MUS or 
medically explained physical symptoms. This service should 
focus on the burden experienced by the person regarding the 
physical symptoms and provide treatment for that, and this 
is in line with the new focus in the DSM-V on emotions, 
cognitions, and behavior regarding the physical symptoms, 
rather than the nature of the physical symptom, ie, whether it 
is explained or unexplained per se. Furthermore, the finding 
that the number of treatment contacts does not differ substan-
tially in the case of concomitant mental disorders shows that 
the focus of treatment does not differ greatly in such cases. 
We also learn that further research about treatment options 
should focus on combined MUS and PHY rather than on 
unselected population-based samples.
Still to be researched is the course of MUS; in other 
words, do people with unexplained physical symptoms get 
better?49 Another question concerns what factors predict 
their prognosis. Further research could also focus on the 
content of the delivered care, the role of consultation,50,51 and 
the achieved results in terms of improvement of health and 
general functioning. As we only focused on the amount of 
care, further research could also study possible benefits of 
disease management programs for patients with both physical 
and mental disorders.52–55
Generalizability
NEMESIS-2 is a large, nationally representative sample of 
the adult Dutch general population. Therefore, the results can 
be extrapolated to the general population of the Netherlands. 
Whether findings are similar in other European countries 
or vary according to health care systems and welfare level 
should be the subject of further research.
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